NCI | Technology Transfer

Compounds for Cancer Chemotherapeutic Sensitization

Read more about Compounds for Cancer Chemotherapeutic Sensitization

US Application 62/626,520
Filed on 2018-02-05

GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU

Read more about GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU

US Application 62/803,468
Filed on 2019-02-09

High Affinity Monoclonal Antibodies Targeting Glypican-1 For Treating Pancreatic Cancer

Read more about High Affinity Monoclonal Antibodies Targeting Glypican-1 For Treating Pancreatic Cancer

US Application 62/795,415
Filed on 2019-01-22

INSERT FOR PREPARING CELL CULTURE CHAMBERS

Read more about INSERT FOR PREPARING CELL CULTURE CHAMBERS

US Application 63/058,794
Filed on 2020-07-30

Small Particle Calibration Kit For Flow Cytometry

Read more about Small Particle Calibration Kit For Flow Cytometry

US Application 62/791,327
Filed on 2019-01-11

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

US Application 62/795,203
Filed on 2019-01-22

RECOMBINANT MOLECULES CONTAINING LINKER FOR ACTIVATION OF T CELLS AND THEIR USE IN IMMUNOTHERAPY

Read more about RECOMBINANT MOLECULES CONTAINING LINKER FOR ACTIVATION OF T CELLS AND THEIR USE IN IMMUNOTHERAPY

US Application 62/819,386
Filed on 2019-03-15

Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors

Read more about Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors

US Application 62/789,650
Filed on 2019-01-08

Compositions and Methods For Treating Cancer With Anti-CD33 Immunotherapy

Read more about Compositions and Methods For Treating Cancer With Anti-CD33 Immunotherapy

US Application 62/620,139
Filed on 2018-01-22

Measurement Of Heterodimer Complex Of BIM---Bcl-2, BIM---Bcl-xL, BIM---Mcl-1 And BAX---BAK As Diagnostic Test Of Patient Sensitivity To BH3 Mimetics

Read more about Measurement Of Heterodimer Complex Of BIM---Bcl-2, BIM---Bcl-xL, BIM---Mcl-1 And BAX---BAK As Diagnostic Test Of Patient Sensitivity To BH3 Mimetics

US Application 62/798,615
Filed on 2019-01-30

Subscribe to NCI